Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Induct ASOSL:INDCT 48 EV-to-EBIT is -4.15 as of Jul. 30, 2026. GuruFocus rates OSL:INDCT with a GF Score™ of 48/100 and a GF Value™ of kr2.29 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Induct AS ranks worse than 212314.01% on this metric.
The historical rank and industry rank for Induct AS's EV-to-EBIT or its related term are showing as below:
OSL:INDCT'
s EV-to-EBIT Range Over the Past 10 Years
Min: -148.64 Med: -15.92 Max: 125.13
Current: -4.15
During the past 11 years, the highest EV-to-EBIT of Induct AS was 125.13. The lowest was -148.64. And the median was -15.92.
OSL:INDCT's EV-to-EBIT is ranked worse than 100% of 471
companies
in the Healthcare Providers & Services industry
Industry Median: 15.73
vs OSL:INDCT: -4.15
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Induct AS's Enterprise Value for the quarter that ended in Mar. 2026 was kr106.43 Mil.
Induct AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-7.04 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Induct AS EV-to-EBIT Related Terms
Induct AS EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Induct AS's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:INDCT vs VEEV, BTSG, HQY: EV-to-EBIT Comparison
For the Health Information Services subindustry, Induct AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Induct AS EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Induct AS's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Induct AS's EV-to-EBIT falls into.
Induct AS's current Enterprise Value is kr29.19 Mil.
Induct AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-7.04 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Induct AS (OSL:INDCT) has a EV-to-EBIT of -4.15 as of Jul. 30, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Induct AS and its competitors. According to the industry distribution chart, Induct AS ranks #999999 out of 471 companies in the Healthcare Providers & Services industry.
Is Induct AS's EV-to-EBIT too high?
Induct AS's current EV-to-EBIT is -4.15. Based on the distribution chart, Induct AS ranks #999999 out of 471 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Induct AS has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Induct AS's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Induct AS ranks #999999 out of 471 companies for EV-to-EBIT. This places Induct AS in the lower half of its industry. The industry median EV-to-EBIT is 15.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.73, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Induct AS and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Induct AS's current EV-to-EBIT is -4.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Induct AS stock overvalued right now?
Based on GuruFocus' analysis, Induct AS (OSL:INDCT) is currently considered Possible Value Trap. The stock's GF Value™ is kr2.29, compared to a current price of kr0.88 — trading 61.5% below its estimated fair value. The current EV-to-EBIT is -4.15. Induct AS's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Induct AS (OSL:INDCT), the current EV-to-EBIT is -4.15 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Induct AS (OSL:INDCT) Overvalued in 2026?
Based on GuruFocus' analysis, Induct AS stock appears to be undervalued.
The current stock price of kr0.88 is trading 61.5% below its estimated GF Value™ of kr2.29.
GuruFocus considers Induct AS to be Possible Value Trap.
Key valuation signals for OSL:INDCT:
EV-to-EBIT: -4.15
GF Value™: kr2.29 vs. price of kr0.88 (61.5% below fair value)
No single metric tells the full story. See the OSL:INDCT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Induct AS is engaged in the business of software development. It offers a digital platform for work and collaboration, for individuals, Homes, Organizations, and Work.
48GF Score
Get the complete analysis for OSL:INDCT
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:INDCT has been successfully added to your 
